CADTH is inviting stakeholders to attend an information and feedback session on 5 February 2015 regarding phase II of the transition of pCODR to CADTH, including the work to better align the pCODR and CADTH Common Drug Review processes.

For more details, go to: http://www.cadth.ca/en/events/2015/stakeholder-engagement-sessions-transfer-of-pcodr